Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (91-100 of 323) with videos related to

Pageof 33
Sort By:
Biomedical Physics & Engineering Express|July 20, 2022
Theoretical and experimental evaluation of the distance dependence of fiber-based fluorescence and reflection measurements for laser lithotripsyBirgit Lange, Tomasz Ozimek, Judith Riccarda Wießmeyer, et al.
World Journal of Urology|March 12, 2013
Phosphodiesterase type 5 (PDE5) is co-localized with key proteins of the nitric oxide/cyclic GMP signaling in the human prostateStefan Ückert, Eginhard S Waldkirch, Axel S Merseburger, et al.
World Journal of Urology|November 27, 2025
Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9Amit Bahl, Andrew Chilelli, Rita Faria, et al.
Scandinavian Journal of Urology and Nephrology|July 11, 2008
An update on the medical therapy of advanced metastatic renal cell carcinomaStephan Kruck, Axel S Merseburger, Georgios Gakis, et al.
Reviews on Recent Clinical Trials|September 11, 2008
Novel therapeutic options in metastatic renal cancer - review and post ASCO 2007 updateStephan Kruck, Markus A Kuczyk, Georgios Gakis, et al.
BJU International|September 8, 2005
Current aspects of the surgical management of organ-confined, metastatic, and recurrent renal cell cancerMarkus A Kuczyk, Aristotelis G Anastasiadis, R Zimmermann, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 7, 2009
Metastasis of malignant melanoma in the ureter: possible algorithms for a therapeutic approachGeorgios Gakis, Axel S Merseburger, Karl Sotlar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 28, 2016
C-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancerAnca Azoitei, Axel S Merseburger, Beate Godau, et al.
Springerplus|October 9, 2013
Bladder cancer discussed on the internet: a systematic analysis of gender differences of initial posters on an online discussion boardYannick Lippka, Oliver Patschan, Tilmann Todenhöfer, et al.
Deutsches Arzteblatt International|August 1, 2022
The Treatment of Metastatic, Hormone-Sensitive Prostatic CarcinomaAxel S Merseburger, Laura-Maria Krabbe, Bernd Joachim Krause, et al.
Pageof 33

Showing results (91-100 of 323) with videos related to

Sort By:
Pageof 33
Biomedical Physics & Engineering Express|July 20, 2022
Theoretical and experimental evaluation of the distance dependence of fiber-based fluorescence and reflection measurements for laser lithotripsyBirgit Lange, Tomasz Ozimek, Judith Riccarda Wießmeyer, et al.
World Journal of Urology|March 12, 2013
Phosphodiesterase type 5 (PDE5) is co-localized with key proteins of the nitric oxide/cyclic GMP signaling in the human prostateStefan Ückert, Eginhard S Waldkirch, Axel S Merseburger, et al.
World Journal of Urology|November 27, 2025
Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9Amit Bahl, Andrew Chilelli, Rita Faria, et al.
Scandinavian Journal of Urology and Nephrology|July 11, 2008
An update on the medical therapy of advanced metastatic renal cell carcinomaStephan Kruck, Axel S Merseburger, Georgios Gakis, et al.
Reviews on Recent Clinical Trials|September 11, 2008
Novel therapeutic options in metastatic renal cancer - review and post ASCO 2007 updateStephan Kruck, Markus A Kuczyk, Georgios Gakis, et al.
BJU International|September 8, 2005
Current aspects of the surgical management of organ-confined, metastatic, and recurrent renal cell cancerMarkus A Kuczyk, Aristotelis G Anastasiadis, R Zimmermann, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 7, 2009
Metastasis of malignant melanoma in the ureter: possible algorithms for a therapeutic approachGeorgios Gakis, Axel S Merseburger, Karl Sotlar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 28, 2016
C-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancerAnca Azoitei, Axel S Merseburger, Beate Godau, et al.
Springerplus|October 9, 2013
Bladder cancer discussed on the internet: a systematic analysis of gender differences of initial posters on an online discussion boardYannick Lippka, Oliver Patschan, Tilmann Todenhöfer, et al.
Deutsches Arzteblatt International|August 1, 2022
The Treatment of Metastatic, Hormone-Sensitive Prostatic CarcinomaAxel S Merseburger, Laura-Maria Krabbe, Bernd Joachim Krause, et al.
Pageof 33